COMPANY
NanoNewron
Funding and NIH signals
- NIH award NIH awarded $1.52M (STTR Phase II 5R42AG080864-03, continuation, notice Jun 3, 2026). NIH RePORTER 5R42AG080864-03 (Jun 3, 2026)
Evidence (1 event)
- Jun 3, 2026 · NIH RePORTER 5R42AG080864-03
Organization: NANONEWRON LLC; City/State: Union, NJ; Project number: 5R42AG080864-03; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-06-03; FY total cost (award amount): 1519969; Administering IC: National Institute on Aging; Project title: Development of a therapeutic nanobody targeting brain TNFa for the treatment of Alzheimer Disease; Organization type: Domestic For-Profits
- Jun 3, 2026 · NIH RePORTER 5R42AG080864-03
Timeline
- Grant Government grant: $2.5M (total, as published), announced Sep 10, 2025. Source: company release on GlobeNewswire. source ↗
Funding
- Government grant: $2.5M (total, as published), announced Sep 10, 2025. Source: company release on GlobeNewswire. source ↗
NIH awards 3
- NIH award 5R42AG080864-03 FY2026: $1,519,969 awarded for that fiscal year; activity R42 (STTR); PI TAGLIETTI, MARCO; recipient as written: NANONEWRON LLC, Union, NJ. Development of a therapeutic nanobody targeting br source ↗
- NIH award 2R42AG080864-02 FY2025: $979,592 awarded for that fiscal year; activity R42 (STTR); PI TAGLIETTI, MARCO; recipient as written: NANONEWRON LLC, Union, NJ. Development of a therapeutic nanobody targeting brai source ↗
- NIH award 1R41AG080864-01A1 FY2023: $499,828 awarded for that fiscal year; activity R41 (STTR); PI FIORITI, LUANA; recipient as written: NANONEWRON LLC, Union, NJ. Discovery of therapeutic nanobodies targeting brain source ↗